Tianyu Qin
P.R. China
Wuhan, China
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Risk prediction model of survival in patients with low-grade serous ovarian cancer: a multicenter Cohort study.
Journal: Journal of ovarian research
Published: October 31, 2025
Spatial tumor evolution panorama of ovarian cancer.
Journal: Cell reports. Medicine
Published: July 12, 2025
Heterogeneous cellular responses to hyperthermia support combined intraperitoneal hyperthermic immunotherapy for ovarian cancer mouse models.
Journal: Science translational medicine
Published: March 12, 2025
Spatial-Temporal Diversity of Extrachromosomal DNA Shapes Urothelial Carcinoma Evolution and the Tumor Immune Microenvironment.
Journal: Cancer discovery
Published: October 20, 2024
The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy.
Journal: Cell reports
Published: April 13, 2024
Genomic profiling of a multi-lineage and multi-passage patient-derived xenograft biobank reflects heterogeneity of ovarian cancer.
Journal: Cell reports. Medicine
Published: January 09, 2024
Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response.
Journal: Nature genetics
Published: April 07, 2023
MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
Journal: Cell & bioscience
Published: March 30, 2023
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors.
Journal: Journal for immunotherapy of cancer
Published: March 20, 2023
Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation.
Journal: Nature communications
Published: March 09, 2023
Last Updated: 09/26/2026